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Type 1 diabetic mothers’ infants show a delay of visual evoked potential (VEP) signiﬁcantly related to some parameters of poor
metabolic control during pregnancy. In the present paper we analyzed the characteristics of VEPs and somatosensory evoked
potentials(SEPs)recordedin16three-year-oldtype1diabeticmothers’children(DMC).Comparedwithcontrols(23nondiabetic
mothers’healthymatchedchildren),DMCshowedsigniﬁcantlydelayedmeanlatencyofVEP(P2)andSEP(P22).In3cases(19%),
we found pathological responses (+3 SD from the mean value of controls) of VEPs and SEPs. At the age of 3 years, the oﬀspring of
type 1 diabetic mothers showed delay of cortical evoked responses in both visual and somatosensory systems.
1.Introduction
Evoked potentials are commonly used in clinical practice
to study brain maturation and clinical disorders [1–3].
Diabetic patients frequently show abnormal evoked poten-
tials, usually related to neuropathy, retinopathy, and poor
metabolic control [4, 5]. Subclinical CNS dysfunctions
have been reliably detected by evoked potentials in adult
patients with uncomplicated diabetes and normal brain
CT scan [6]. Moreover, evoked potentials are sensitive to
drug administration eﬀects and prenatal substance exposure
[7, 8]. In previous studies [9, 10] on diabetic mothers’
infants, we found a delayed mean latency of the fourth (P2)
component of VEPs compared to matched healthy infants.
These results were signiﬁcantly related to some parameters
of poor metabolic control during pregnancy in type 1
diabetic mothers’ infants; on the contrary, in infants born
from mothers with gestational diabetes VEPs did not show
any signiﬁcant relation with metabolic parameters during
pregnancy, but latencies correlated with Apgar scores of
perinatal distress. These features suggest that in the oﬀspring
of type 1 diabetic mothers VEP changes may be related to
adverse eﬀects due to exposure of the fetus to metabolic
imbalance during intrauterine life.
These observations raise two main points: (i) whether
the VEP abnormalities recorded at the age of 2 months
are transient and (ii) whether the abnormalities of evoked
responses are restricted to the visual system or extended to
other cortical structures. To investigate both these aspects, in
the present study we analyzed the characteristics of VEPs and
somatosensory evoked potentials (SEPs) recorded in 3-year-
old type 1 diabetic mothers’ children (DMC).
2.MaterialsandMethods
2.1. Sample. We studied VEPs and SEPs of 16 three-year-
old children (11 females, 5 males, mean age 2.6 ± 0.9y e a r s ) ,
whose mothers suﬀered of type 1 diabetes. VEPs had already
been recorded at the age of two months (24 infants, 8
missing cases; 33% attrition rate between 2 months and
3 years). VEPs and SEPs were obtained according to the
American Electroencephalographic Society guidelines [11]
with electrodes placement based on the International 10–20
System. Recordings were performed without knowledge of2 Experimental Diabetes Research
mothers’ antepartum metabolic status and infants’ perinatal
history. Informed consent was obtained from each child’s
parents after explaining to them the procedures’ nature and
purpose. A matched sample of 23 nondiabetic mothers’
healthy children was used as control.
2.2. VEP Recording. VEPs were recorded in a partially
darkened room (mean background light 0.15ft-Lamberts;
darkadaptationfor20minutes)inawakecondition(without
sedation). The state of alertness was carefully checked during
the entire recording session. VEPs were elicited by binocular
stimulation with a stroboscopic unpatterned ﬂash (white
light; intensity 0.3Joule; frequency 1Hz) placed about 25cm
from the eyes. Responses were recorded from silver-silver
chloride electrodes applied to the occipital region, using a
four-channel montage (O1-Fz, Oz-Fz, O2-Fz, Fz-M1; M2
as ground). At least two trials of 100 artifact-free responses
(automatic artifact rejection; amplitude threshold <20% of
rejected traces) were recorded within 512ms after stimulus.
2.3.SEPRecording. SEPswereobtainedinconscioussubjects
(without sedation) checking the alertness during the entire
recording session. Responses were elicited by electrical
stimulation applied on the left median nerve at the wrist
using a constant current square wave pulse (0.1ms width,
cathode proximal) at a repetition rate of 4Hz. The stimulus
intensity was regulated to produce a small thumb twitch.
Cortical responses were recorded by surface silver-silver
chloride electrodes placed on the contralateral parietal and
frontal areas with two channel montage with an active
electrode on C4  (2cm posterior to C4 in the International
10–20 System) referenced to Fz, and an active electrode on
F4 referenced to C3 . At least two trials of 250 artifact-free
samples (automatic artifact rejection; amplitude threshold
<20% of rejected traces) were recorded with an analysis time
of 100ms.
All reproducible peaks of VEPs and SEPs were identiﬁed
and labelled according to the American Electroencephalo-
graphic Society guidelines [11]. Peak latencies and peak-
to-peak amplitudes of all components were measured but
only the most stable components were used for statistical
comparisons(III,IV,andVforVEPs;N20andP22forSEPs).
Pathological responses were considered when latency value
was more than 3SD from the mean value of controls.
2.4. Statistical Analysis. Means and limits were calculated
adopting tolerance limit of 99% with a conﬁdence of 95%.
ToobtainnormativedataforVEPsandSEPs,thedistribution
of observed values was previously examined by the Shapiro-
Will’s goodness of ﬁt for skewness and/or kurtosis. Statistical
analysis was performed by software (STATISTICA 9.1-
StatSoft, Inc., OK, USA), using ANOVA with post hoc
comparison (Bonferroni test for multiple comparisons),
nonparametric tests, and χ2 with Yates correction when
appropriate. Statistical signiﬁcance was deﬁned as P<0.05.
3. Results
DMC showed mean latency of all VEP components signif-
icantly increased compared with controls at the age of two
months and the forth (P2) component was still delayed at
the age of three years (Table 1). No diﬀerences were found
for VEP amplitudes.
The P22 component of SEP was signiﬁcantly delayed
compared with controls (Table 2) whereas no diﬀerences
werefoundforN20latencyandforamplitudesofbothwaves.
Pathological responses of VEPs and SEPs were found in 3
cases (19%).
4. Discussion
At the age of two months, type 1 diabetic mothers’ oﬀspring
showed that all VEP latencies were increased than controls,
and this ﬁnding is still evident at the age of three years for
the fourth VEP component (P2). The cortical origin of this
wave is well documented by multichannel scalp recordings
and clinical studies [12, 13]. According to the hypothesis of
subcortical-cortical development, during the ﬁrst postnatal
weeks, the visual system is under the prevailing control of
subcorticalcentres,afterwardstheprimarygeniculocalcarine
cortical system assumes the major control, due to synapto-
genesis and myelination [14]. Visual processes continue to
mature during childhood and these changes may be well
documented by VEP recording, as a decrease in latency, an
increase in amplitude, and a development of the waveform
[15, 16]. Data of VEPs in our sample suggest the occurrence
of adverse eﬀects of maternal diabetes on visual system
especially at cortical level; these eﬀects are not limited to the
neonatal period but appear to be persistent, at least in the
ﬁrst 3 years of age.
Regarding SEPs, we found a delay in the P22 but not
in the N20 component. These waves represent the initial
response of the primary somatosensory cortex to stimu-
lation of the upper extremity. Clinical and experimental
data suggest diﬀerential generators for N20 and P22 (N20
generator in the postcentral gyrus-S1, Brodmann area 3b;
P22 generator assigned either to the area 4 in the precentral
gyrus either to area 1 in the postcentral gyrus) [17, 18]. Our
data are consistent with these observations, and they support
the possibility of separate functional testing of Brodmann
areas, as recently reported [19]. Moreover, the delay of the
P22 component in the oﬀspring of diabetic mothers suggests
that eﬀects of metabolic imbalance during the intrauterine
life are not conﬁned to the visual system but act more
diﬀusely.
All these data conﬁrm previous studies on the adverse
eﬀects of maternal diabetes on oﬀspring’s brain development
[20–23]. Cortical dysfunctions could be related to poor
metabolic control, as suggested by clinical and experimental
studies, with subtle negative eﬀects on the oﬀspring’s CNS
[24–26].
Finally, in the present study we found pathological
responses of both VEPs and SEPs in 3 children, currently
asymptomatic. Central nervous system degeneration is a
well-known long-term complication in diabetic patients,Experimental Diabetes Research 3
Table 1: Comparison between DMC and controls for VEP latencies.
Age VEP components
DMC Controls
P∗ Latency (ms) Latency (ms)
Mean ± SD Conﬁdence interval Mean ± SD Conﬁdence interval
−99% +99% −99% +99%
2m o n t h s
Right (O2)
III 136.2 ± 29.9 114.2 158.2 109.0 ± 31.1 89.8 129.3 <0.01
IV 190.9 ± 33.4 166.3 215.5 156.6 ± 30.8 137.4 175.7 <0.01
V 275.8 ± 50.1 238.9 312.8 223.6 ± 47.1 194.4 252.9 <0.01
Left (O1)
III 132.3 ± 29.6 110.5 154.1 108.4 ± 31.6 88.7 128.0 <0.05
IV 187.8 ± 37.1 160.4 215.1 156.7 ± 31.7 137.0 176.4 <0.01
V 267.2 ± 47.3 232.3 302.1 220.1 ± 50.0 189.0 251.1 <0.01
3 years
Right (O2)
III 71.53 ± 15.2 62.3 78.4 67.63 ± 9.0 61.5 74.0 NS
IV 105.53 ± 13.1 98.7 114.5 99.96 ± 8.8 93.8 106.1 <0.05
V 149.03 ± 36.2 133.2 174.2 149.05 ± 22.5 133.5 165.5 NS
Left (O1)
III 74.47 ± 13.4 65.8 81.3 68.02 ± 9.7 62.0 74.0 NS
IV 106.13 ± 14.0 98.4 116.0 98.69 ± 10.2 91.8 105.6 <0.05
V 151.12 ± 43.3 135.9 180.1 150.0 ± 22.4 132.8 167.3 NS
∗ANOVA (post hoc comparison with correction for multiple comparisons—Bonferroni test).
Table 2: Comparison between DMC and controls for SEP latencies.
SEP components
DMC Controls
P∗ Latency (ms) Latency (ms)
Mean ± SD Conﬁdence interval Mean ± SD Conﬁdence interval
−99% +99% −99% +99%
N20 18.11 ± 1.98 14.20 22.02 17.55 ± 1.42 13.87 21.23 NS
P22 24.86 ± 2.38 15.22 34.50 21.71 ± 1.57 14.12 29.30 <0.001
∗ANOVA (post hoc comparison with correction for multiple comparisons—Bonferroni test).
and it is possible to reveal this involvement in an early
asymptomatic stage by using evoked potentials [27, 28].
Neuropsychological deﬁcitshavebeen noted in children with
type 1 diabetes [29], suggesting the occurrence of subtle
negative eﬀects related to diabetes on cognitive development
in school-age children. Recurrent episodes of hypoglycaemia
as well extended periods of hyperglycemia have been
reported as possible causes of brain dysfunction in poorly
controlled diabetic patients [30, 31]. Moreover, the recent
concept of developmental programming postulates long-
term detrimental eﬀects on adult health due to nutritional
imprinting during critical developmental periods; according
to this ﬁnding, alterations and/or modiﬁcations in nutrients
supply during fetal and neonatal life may be associated with
abnormal growth patterns, resulting in the development of
future diseases [32–36]. To clarify the clinical signiﬁcance
of the abnormal evoked responses found in our sample, we
are carrying out a clinical and neurophysiologic followup of
these children.
5. Conclusions
Type 1 diabetes mothers’ oﬀspring showed a signiﬁcant
delay of cortical evoked responses to both visual and
somatosensory stimulation compared with controls. These
results do not seem to be transient, since the delay of
VEP found in the neonatal period is still present at the
age of three years. The recording of evoked potentials may
be proposed as a useful tool of investigation since it is
particularly sensitive to highlight functional abnormalities of
the CNS.
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